Azitra Regains Compliance with NYSE Listing Standards

Azitra, Inc. has been notified by NYSE American that it has resolved continued listing deficiencies under Sections 1003(a)(ii) and 1003(a)(iii) and will no longer carry the '.BC' indicator. The company maintains a focus on its clinical development pipeline and adherence to listing requirements.